{"id":3662998,"date":"2025-02-04T06:32:36","date_gmt":"2025-02-04T11:32:36","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/?post_type=story&p=3662998"},"modified":"2025-02-04T06:32:37","modified_gmt":"2025-02-04T11:32:37","slug":"our-q4-and-full-year-2024-financial-results","status":"publish","type":"story","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/stories\/our-q4-and-full-year-2024-financial-results\/","title":{"rendered":"Our Q4 and full-year 2024 financial results"},"content":{"rendered":"\n
\n
\n \n \n Innovation<\/small>\n <\/a>\n \n \n

\n Our Q4 and full-year 2024 financial results\n <\/h1>\n <\/div>\n\n
\n

February 4, 2025<\/p>\n

\n

Share this article<\/p>\n

\n \nFacebook icon<\/title><\/svg>\n<\/a><\/p>\n

\n\n\n\n\t.st0{fill:#00857C;}\n\n\nX icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nLinkedin icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nEmail icon<\/title><\/svg>\n<\/a><\/p>\n <\/div>\n <\/div>\n\n
\n
\n
\n \n \n \n \n \"illustration\n <\/picture>\n\n <\/figure>\n \n <\/div>\n <\/div>\n\n
\n
\n
\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n\n

Merck\u2019s (NYSE: MRK<\/a>) Q4 and full-year 2024 results reflect strong growth. Our company announced Q4 worldwide sales of $15.6 billion, an increase of 7% from Q4 2023. Full-year 2024 worldwide sales were $64.2 billion, an increase of 7% from full-year 2023. \u200b<\/p>\n\n\n\n

\u200b\u201cWe delivered strong growth in 2024, reflecting demand for our innovative portfolio, including for KEYTRUDA, the successful launch of WINREVAIR and strong performance of our Animal Health business,\u201d said Rob Davis, chairman and chief executive officer. “We\u2019re continuing to progress our pipeline, advance key clinical programs and augment our pipeline through promising business development. Our business remains well positioned thanks to the dedication of our talented global team, and I am more confident than ever in our long-term growth potential.\u201d\u200b<\/p>\n\n\n\n

\u200bMerck anticipates full-year 2025 worldwide sales to be between $64.1 billion and $65.6 billion.\u200b<\/p>\n\n\n\n

Find more details on Q4 and full-year 2024 results below.\u200b<\/p>\n\n\n\n

<\/p>\n\n\n\n

\n
\n

Listen to the sales and earnings call<\/a><\/p>\n<\/div>\n\n\n\n

\n

Read the press release<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n \n \n\n \n \n
\n \n \n \n \n \n <\/picture>\n <\/div>\n <\/section>\n<\/div>\n